French researchers have discovered that an anti-rejection drug could treat Huntington's disease. Intellectual Property based on the research is available for licence.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.